Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             98 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Acquired TTP: ADAMTS13 meets the immune system Verbij, Fabian C.
2014
6 p. 227-234
8 p.
artikel
2 Acute myeloid leukemia with mutated nucleophosmin (NPM1): Any hope for a targeted therapy? Falini, Brunangelo
2011
6 p. 247-254
8 p.
artikel
3 Advances in stem cell mobilization Motabi, Ibraheem H.
2012
6 p. 267-278
12 p.
artikel
4 Allogeneic hematopoietic cell transplantation for MDS: For whom, when and how? Gyurkocza, Boglarka
2012
6 p. 247-254
8 p.
artikel
5 Allogeneic stem cell transplantation in acute myeloid leukemia: a risk-adapted approach Lodewyck, Tom
2008
6 p. 293-302
10 p.
artikel
6 Anaemia of prematurity: Pathophysiology and treatment Strauss, Ronald G.
2010
6 p. 221-225
5 p.
artikel
7 Atrial fibrillation and coagulation: Who and when? Fitzmaurice, David
2009
6 p. 241-244
4 p.
artikel
8 Beta thalassemia in 31,734 cases with HBB gene mutations: Pathogenic and structural analysis of the common mutations; Iran as the crossroads of the Middle East Mahdieh, Nejat
2016
6 p. 493-508
16 p.
artikel
9 Beyond the HLA typing age: Genetic polymorphisms predicting transplant outcome Dickinson, Anne M.
2005
6 p. 333-340
8 p.
artikel
10 Biosimilars: A cure to the U.S. health care cost conundrum? Hirsch, Bradford R.
2014
6 p. 263-268
6 p.
artikel
11 Bleeding and thrombotic complications of kidney disease Pavord, Sue
2011
6 p. 271-278
8 p.
artikel
12 Blocking “don't eat me” signal of CD47-SIRPα in hematological malignancies, an in-depth review Russ, Atlantis
2018
6 p. 480-489
artikel
13 Blood and marrow transplantation for sickle cell disease: Is less more? Bolaños-Meade, Javier
2014
6 p. 243-248
6 p.
artikel
14 Blood coagulation factor XIII and factor XIII deficiency Dorgalaleh, Akbar
2016
6 p. 461-475
15 p.
artikel
15 Clinical approach to diffuse large B cell lymphoma Caimi, Paolo F.
2016
6 p. 477-491
15 p.
artikel
16 CNS prophylaxis in lymphoma: Who to target and what therapy to use Hill, Quentin A.
2006
6 p. 319-332
14 p.
artikel
17 Contents 2018
6 p. iii
artikel
18 Corrigendum to “Von Willebrand factor and ADAMTS13 in arterial thrombosis: A systematic review and meta-analysis” [Blood Rev 28 (2014) 167–178] Sonneveld, Michelle A.H.
2014
6 p. 281-282
2 p.
artikel
19 Could stem cells be the future therapy for sepsis? Kingsley, S. Manoj Kumar
2016
6 p. 439-452
14 p.
artikel
20 Current status and trends in the diagnostics of AML and MDS Shumilov, Evgenii
2018
6 p. 508-519
artikel
21 De novo thrombotic microangiopathy after non-renal solid organ transplantation Verbiest, Annelies
2014
6 p. 269-279
11 p.
artikel
22 Deregulated JAK/STAT signalling in lymphomagenesis, and its implications for the development of new targeted therapies Scott, Linda M.
2015
6 p. 405-415
11 p.
artikel
23 Diagnosis and management of the antiphospholipid syndrome Chaturvedi, Shruti
2017
6 p. 406-417
12 p.
artikel
24 Diagnosis of megaloblastic anaemias Wickramasinghe, S.N.
2006
6 p. 299-318
20 p.
artikel
25 Dickkopf-1 is a key regulator of myeloma bone disease: Opportunities and challenges for therapeutic intervention Zhou, Fuling
2013
6 p. 261-267
7 p.
artikel
26 Editorial Board 2009
6 p. i-
1 p.
artikel
27 Editorial Board 2018
6 p. i
artikel
28 Eryptosis in health and disease: A paradigm shift towards understanding the (patho)physiological implications of programmed cell death of erythrocytes Qadri, Syed M.
2017
6 p. 349-361
13 p.
artikel
29 Fibrinogen and cardiovascular disease: Genetics and biomarkers Tousoulis, Dimitris
2011
6 p. 239-245
7 p.
artikel
30 From evidence to clinical practice in blood and marrow transplantation Khera, Nandita
2015
6 p. 351-357
7 p.
artikel
31 Frontline treatment of multiple myeloma in elderly patients Moreau, Philippe
2008
6 p. 303-309
7 p.
artikel
32 Genetic causes of erythrocytosis and the oxygen-sensing pathway Lee, Frank S.
2008
6 p. 321-332
12 p.
artikel
33 Haemostatic problems in acute promyelocytic leukaemia Arbuthnot, Carolina
2006
6 p. 289-297
9 p.
artikel
34 Harnessing the power of alloreactivity without triggering graft-versus-host disease: how non-engrafting alloreactive cellular therapy might change the landscape of acute myeloid leukemia treatment Krakow, Elizabeth F.
2014
6 p. 249-261
13 p.
artikel
35 Hemophagocytic syndromes (HPSs) including hemophagocytic lymphohistiocytosis (HLH) in adults: A systematic scoping review Hayden, Anna
2016
6 p. 411-420
10 p.
artikel
36 Hemophilic arthropathy in patients with von Willebrand disease van Galen, K.P.M.
2012
6 p. 261-266
6 p.
artikel
37 Hereditary haemorrhagic telangiectasia: Pathophysiology, diagnosis and treatment Shovlin, Claire L.
2010
6 p. 203-219
17 p.
artikel
38 How Will Haematologists Use Proteomics? Unwin, Richard D.
2007
6 p. 315-326
12 p.
artikel
39 Hyperferritinemia and iron metabolism in Gaucher disease: Potential pathophysiological implications Regenboog, Martine
2016
6 p. 431-437
7 p.
artikel
40 Immunotherapeutic strategies in acute lymphoblastic leukaemia relapsing after stem cell transplantation Blair, Allison
2005
6 p. 289-300
12 p.
artikel
41 Improving outcomes in umbilical cord blood transplantation: State of the art Cutler, Corey
2012
6 p. 241-246
6 p.
artikel
42 Induction therapy for elderly patients with acute myeloid leukemia Martin, Mike G.
2008
6 p. 311-320
10 p.
artikel
43 Infections in patients with chronic lymphocytic leukaemia: Mitigating risk in the era of targeted therapies Teh, Benjamin W.
2018
6 p. 499-507
artikel
44 Iron and transfusion medicine Waldvogel-Abramovski, Sophie
2013
6 p. 289-295
7 p.
artikel
45 Iron toxicity – Its effect on the bone marrow Isidori, Alessandro
2018
6 p. 473-479
artikel
46 Lyse or not to lyse: Clinical significance of red blood cell autoantibodies Meulenbroek, Elisabeth M.
2015
6 p. 369-376
8 p.
artikel
47 Management of indolent lymphoma: Where are we now and where are we going Lunning, Matthew A.
2012
6 p. 279-288
10 p.
artikel
48 Management of multiple myeloma: The changing landscape Reece, Donna E.
2007
6 p. 301-314
14 p.
artikel
49 Management of sickle cell disease from childhood through adulthood Kanter, Julie
2013
6 p. 279-287
9 p.
artikel
50 Managing critically Ill hematology patients: Time to think differently Azoulay, Elie
2015
6 p. 359-367
9 p.
artikel
51 Managing resistance in chronic myeloid leukemia Roychowdhury, Sameek
2011
6 p. 279-290
12 p.
artikel
52 Milestones in umbilical cord blood transplantation Gluckman, E.
2011
6 p. 255-259
5 p.
artikel
53 Myelodysplasic syndromes: A comprehensive review Catenacci, Daniel V.T.
2005
6 p. 301-319
19 p.
artikel
54 Myeloid-derived suppressor cells in lymphoma: The good, the bad and the ugly Betsch, A.
2018
6 p. 490-498
artikel
55 Neutrophil extracellular traps (NETs) and infection-related vascular dysfunction Gardiner, Elizabeth E.
2012
6 p. 255-259
5 p.
artikel
56 Notch signaling in hematopoietic cell transplantation and T cell alloimmunity Ebens, Christen L.
2013
6 p. 269-277
9 p.
artikel
57 Novel treatment strategies for patients with relapsed classical Hodgkin lymphoma Jona, Adam
2010
6 p. 233-238
6 p.
artikel
58 Opportunities and limitations of bone marrow biopsy and bone marrow FDG-PET in lymphoma Adams, Hugo J.A.
2015
6 p. 417-425
9 p.
artikel
59 Palliative care and hematologic oncology: The promise of collaboration Epstein, Andrew S.
2012
6 p. 233-239
7 p.
artikel
60 Pathways towards indolent B-cell lymphoma — Etiology and therapeutic strategies van den Brand, Michiel
2017
6 p. 426-435
10 p.
artikel
61 Plasma contact factors as therapeutic targets Tillman, Benjamin F.
2018
6 p. 433-448
artikel
62 Platelet populations and priming in hematological diseases Baaten, Constance C.F.M.J.
2017
6 p. 389-399
11 p.
artikel
63 Platelets and physics: How platelets “feel” and respond to their mechanical microenvironment Qiu, Yongzhi
2015
6 p. 377-386
10 p.
artikel
64 POEMS syndrome Dispenzieri, Angela
2007
6 p. 285-299
15 p.
artikel
65 Prophylactic therapy in haemophilia Ljung, Rolf
2009
6 p. 267-274
8 p.
artikel
66 Recipient and donor cells in the graft-versus-solid tumor effect: It takes two to tango Dierckx de Casterlé, Isabelle
2018
6 p. 449-456
artikel
67 Renal complications in transfusion-dependent beta thalassaemia Ponticelli, Claudio
2010
6 p. 239-244
6 p.
artikel
68 Resuscitation and transfusion principles for traumatic hemorrhagic shock Spinella, Philip C.
2009
6 p. 231-240
10 p.
artikel
69 Subject Index 2005
6 p. IV-X
nvt p.
artikel
70 Subject Index 2010
6 p. V-IX
nvt p.
artikel
71 Subject Index: Volume 23 (2009) 2009
6 p. V-XII
nvt p.
artikel
72 Subject Index: Volume 20 (2006) 2006
6 p. IV-XI
nvt p.
artikel
73 Subject Index: Volume 22 (2008) 2008
6 p. V-XII
nvt p.
artikel
74 Targeting the ubiquitin proteasome system in haematological malignancies Crawford, Lisa J.
2013
6 p. 297-304
8 p.
artikel
75 T-cell acute lymphoblastic leukemia from miRNA perspective: Basic concepts, experimental approaches, and potential biomarkers Drobna, Monika
2018
6 p. 457-472
artikel
76 Telomere biology in hematopoiesis and stem cell transplantation Gadalla, Shahinaz M.
2011
6 p. 261-269
9 p.
artikel
77 The clinical and biological impact of new pathogen inactivation technologies on platelet concentrates Kaiser-Guignard, Julie
2014
6 p. 235-241
7 p.
artikel
78 The contribution of different adipose tissue depots to plasma plasminogen activator inhibitor-1 (PAI-1) levels Barnard, Sunelle A.
2016
6 p. 421-429
9 p.
artikel
79 The incidental monoclonal protein: Current approach to management of monoclonal gammopathy of undetermined significance (MGUS) Madan, Sumit
2009
6 p. 257-265
9 p.
artikel
80 The post-PE syndrome: a new concept for chronic complications of pulmonary embolism Klok, F.A.
2014
6 p. 221-226
6 p.
artikel
81 Therapeutic potential of embryonic stem cells Lerou, Paul H.
2005
6 p. 321-331
11 p.
artikel
82 Therapeutic use of transferrin to modulate anemia and conditions of iron toxicity Boshuizen, M.
2017
6 p. 400-405
6 p.
artikel
83 The 2016 revision of WHO classification of myeloproliferative neoplasms: Clinical and molecular advances Barbui, T.
2016
6 p. 453-459
7 p.
artikel
84 The skin as a window to the blood: Cutaneous manifestations of myeloid malignancies Li, Alvin W.
2017
6 p. 370-388
19 p.
artikel
85 The who, how and why: Allogeneic transplant for acute myeloid leukemia in patients older than 60years Wall, Sarah A.
2017
6 p. 362-369
8 p.
artikel
86 Thrombohemorrhagic complications of myeloproliferative disorders Papadakis, Emmanouil
2010
6 p. 227-232
6 p.
artikel
87 Transfusion-related acute lung injury (TRALI): Current concepts and misconceptions Silliman, Christopher C.
2009
6 p. 245-255
11 p.
artikel
88 Transfusion-related immunomodulation (TRIM): An update Vamvakas, Eleftherios C.
2007
6 p. 327-348
22 p.
artikel
89 Treatment for patients with newly diagnosed multiple myeloma in 2015 Mateos, María-Victoria
2015
6 p. 387-403
17 p.
artikel
90 Treatment of acute myeloid leukemia in the next decade – Towards real-time functional testing and personalized medicine Lam, Stephen Sze-Yuen
2017
6 p. 418-425
8 p.
artikel
91 Tumor microenvironment and drug resistance in hematologic malignancies Li, Zhi-Wei
2006
6 p. 333-342
10 p.
artikel
92 Volume and Author Contents 2005
6 p. I-III
nvt p.
artikel
93 Volume Contents and Author Index 2013
6 p. I-IV
nvt p.
artikel
94 Volume Contents and Author Index 2008
6 p. I-IV
nvt p.
artikel
95 Volume Contents and Author Index 2010
6 p. I-IV
nvt p.
artikel
96 Volume Contents and Author Index 2009
6 p. I-IV
nvt p.
artikel
97 Volume Contents and Author Index 2006
6 p. I-III
nvt p.
artikel
98 Volume Contents and Author Index 2011
6 p. I-IV
nvt p.
artikel
                             98 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland